ArticlePloS one2026
Time to treatment initiation in pregnant women with tuberculosis in Cape Town, South Africa.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Infectious comorbidities in pregnant patients with rheumatic diseases.Rheumatology international · 2026Review
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
backgroundTuberculosis (TB) incidence peaks in women during their reproductive years and is a leading cause of maternal mortality. Pregnant women with TB have a high risk of failure to initiate TB treatment and poor TB treatment and pregnancy outcomes. We determined the time to treatment initiation in pregnant women diagnosed with TB in a routine programmatic setting.
methodsUsing routine linked electronic data, we identified women 15-45 years of age with laboratory-confirmed and/or clinically diagnosed TB, October 2018-December 2020, in two high-burden sub-districts in Cape Town, South Africa. We compared demographic and clinical characteristics in women with TB by pregnancy status, used time-to-event analysis to determine the time from TB diagnosis to initiation of antituberculosis treatment and Cox regression to assess determinants of treatment initiation.
resultsOf 5,459 women diagnosed with TB, 292 (5.3%) were pregnant. The median age for pregnant women was 28.6 years (interquartile range [IQR]: 23.7-33.7) and non-pregnant women 31 years (IQR:25.2-36.5). HIV prevalence was similar in pregnant (177/292; 60.6%) vs non-pregnant (3200/5167; 61.9%) women. Median time to treatment initiation was two days for pregnant and non-pregnant women. Most (92% of non-pregnant and 89% of pregnant) women initiated treatment within the first month after their TB diagnosis, after which the rate plateaued in both groups. Time to treatment initiation over 6 months was statistically different (Kaplan Meier Log-rank test, p = 0.0064) with pregnant women lagging behind non-pregnant women.
conclusionsMore than 5% of women diagnosed with TB were pregnant at the time of TB diagnosis. While pregnant women with TB were appropriately initiated on treatment, almost 15% were never started on treatment and there were delays in treatment initiation. While strategic interventions to prioritise early treatment initiation are needed, there should be a specific focus on pregnant women who have not initiated treatment within one month after TB diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.